In-Hospital Outcomes of Transcatheter Aortic Valve Replacement Versus Surgical Aortic Valve Replacement in Obesity

Aortic stenosis (AS) is a degenerative valvular disease that worsens over time. Its prevalence has been significantly increasing over the past 2 decades and is expected to continue to increase with the progressive aging of the population in developed countries.1 Aortic valve replacement is currently the mainstay of treatment of AS with improvement in both mortality and quality of life. Surgical aortic valve replacement (SAVR) has been the standard of care for treatment of AS for many years. However, since the introduction of transcatheter aortic valve replacement (TAVR) in 2002, it has been shown to have similar, or even better, clinical outcomes in patients with at least intermediate surgical risk.
Source: The American Journal of Cardiology - Category: Cardiology Authors: Source Type: research